RIMONDI, ALESSANDRO
RIMONDI, ALESSANDRO
Universita' degli Studi di MILANO
Acquired Refractory Iron Deficiency Anemia
2021 M.M.D. Amicis, A. Rimondi, L. Elli, I. Motta
An unprecedented challenge: The north italian gastroenterologist response to COVID-19
2022 G.E. Tontini, G. Aldinio, N. Nandi, A. Rimondi, D. Consonni, M. Iavarone, P. Cantu, A. Sangiovanni, P. Lampertico, M. Vecchi
Artificial intelligence in gastrointestinal endoscopy for inflammatory bowel disease: a systematic review and new horizons
2021 G.E. Tontini, A. Rimondi, M. Vernero, H. Neumann, M. Vecchi, C. Bezzio, F. Cavallaro
Clinical features of type 1 and 2 refractory celiac disease: Results from a large cohort over a decade
2022 L. Elli, P. Soru, L. Roncoroni, F.G. Rossi, V. Ferla, L. Baldini, N. Nandi, L. Scaramella, A. Scricciolo, A. Rimondi, N. Fusco, G.A. Croci, U. Gianelli, L. Cro, M. Barbieri, V. Lombardo, A. Costantino, V. Vaira, S. Ferrero, G.E. Tontini, G. Barigelletti, S. Fabiano, L. Doneda, M. Vecchi
Endoscopy during the Covid-19 outbreak : experience and recommendations from a single center in a high-incidence scenario
2020 L. Elli, A. Rimondi, L. Scaramella, M. Topa, M. Vecchi, D. Mangioni, A. Gori, R. Penagini
Endoscopy during the COVID-19 pandemic: Is it time to down-grade personal protective equipment for vaccinated personnel?
2021 L. Elli, A. Rimondi, E. Tontini, A. Gori, M. Vecchi, R. Penagini
Fogging IBD Management: An Unusual Case of IBD Flare-up During the COVID-19 Outbreak
2020 A. Rimondi, G.E. Tontini, S. Mazza, F. Caprioli, A. Sangiovanni, P. Lampertico, M. Vecchi
High rates of 30-day mortality in patients with cirrhosis and COVID-19
2020 M. Iavarone, R. D'Ambrosio, A. Soria, M. Triolo, N. Pugliese, P. Del Poggio, G. Perricone, S. Massironi, A. Spinetti, E. Buscarini, M. Vigano, C. Carriero, S. Fagiuoli, A. Aghemo, L.S. Belli, M. Luca, M. Pedaci, A. Rimondi, M.G. Rumi, P. Invernizzi, P. Bonfanti, P. Lampertico
Jejunal necrosis following caustic (NH3) Ingestion in patient with total gastrectomy
2021 N. Nandi, A. Rimondi, G.E. Tontini, M. Vecchi
Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study
2021 S. Mazza, O.S.N. Piazza, F.S. Conforti, A. Fasci, A. Rimondi, B. Marinoni, V. Casini, C. Ricci, F. Munari, L. Pirola, P. Invernizzi, C. Girelli, G. Lupinacci, L. Pastorelli, F. Cavallaro, L. Ferraris, A. Colucci, A. Amato, G. Eugenio Tontini, M. Vecchi, G. Fiorino, F. Caprioli
Safety and effectiveness of up to 3 years' bulevirtide monotherapy in patients with HDV-related cirrhosis
2022 A. Loglio, P. Ferenci, S.C. UCEDA RENTERIA, C. Tham, C. Scholtes, H. Holzmann, F. van Bömmel, M. Borghi, R. Perbellini, A. Rimondi, E. Farina, E. Trombetta, M. Manunta, L. Porretti, D. Prati, F. Ceriotti, F. Zoulim, A. Bertoletti, P. Lampertico